These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6778956)

  • 21. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.
    Bunney BS; Grace AA
    Life Sci; 1978 Oct; 23(16):1715-27. PubMed ID: 31529
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
    Reubi JC; Emson PC; Jessell TM; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):271-5. PubMed ID: 714184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic haloperidol on dopamine release following microinjection of GABA into the substantia nigra zona reticulata in the rat.
    Kamata K; Sugimoto A; Kameyama T
    Brain Res; 1986 Aug; 380(1):1-6. PubMed ID: 3756464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.
    Lloyd KG; Hornykiewics O
    Life Sci; 1977 Nov; 21(10):1489-96. PubMed ID: 927011
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of chronic haloperidol and sulpiride treatment on rat nigral GABA content.
    Rampello L; Giammona G; Patti F; Reggio A; Nicoletti F; Di Giorgio RM; Condorelli DF
    Boll Soc Ital Biol Sper; 1981 Aug; 57(15):1608-11. PubMed ID: 7306401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
    Zarzecki P; Blake DJ; Somjen GG
    Exp Neurol; 1977 Dec; 57(3):956-70. PubMed ID: 200450
    [No Abstract]   [Full Text] [Related]  

  • 29. Rotatory behavior induced by glycine injected into the substantia nigra of the rat.
    Mendez JS; Finn BW; Dahl KE
    Exp Neurol; 1976 Jan; 50(1):174-9. PubMed ID: 1248538
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
    Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
    Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of different doses of apomorphine on GAD activity in rat substantia nigra.
    Condorelli DF; Giammona G; Patti F; Nicoletti F; Rampello L; Reggio A; Matera M; Di Giorgio RM
    Ital J Neurol Sci; 1981 Aug; 2(3):303-6. PubMed ID: 7341553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat.
    Brown LL; Wolfson LI
    Brain Res; 1978 Jan; 140(1):188-93. PubMed ID: 626883
    [No Abstract]   [Full Text] [Related]  

  • 34. A simple approach to study the effect of haloperidol on GABA functional activity in the nigro-striatal system.
    Cattabeni F; Maggi A; DeAngelis L; Bruno F; Racagni G
    J Neurochem; 1977 Jun; 28(6):1407-8. PubMed ID: 874507
    [No Abstract]   [Full Text] [Related]  

  • 35. Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists.
    Pinnock RD
    Eur J Pharmacol; 1983 Dec; 96(3-4):269-76. PubMed ID: 6676108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The substantia nigra and stereotyped behaviour.
    Costall B; Naylor RJ; Olley JE
    Eur J Pharmacol; 1972 Apr; 18(1):95-106. PubMed ID: 4555563
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-type Ca²⁺ channel activity determines modulation of GABA release by dopamine in the substantia nigra reticulata and the globus pallidus of the rat.
    Recillas-Morales S; Sánchez-Vega L; Ochoa-Sánchez N; Caballero-Florán I; Paz-Bermúdez F; Silva I; Aceves J; Erlij D; Florán B
    Neuroscience; 2014 Jan; 256():292-301. PubMed ID: 24505607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
    Koob G; del Fiacco M; Iversen SD
    Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
    [No Abstract]   [Full Text] [Related]  

  • 40. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
    Gallager DW; Pert A; Bunney WE
    Nature; 1978 May; 273(5660):309-12. PubMed ID: 652037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.